company background image
HUMX

Human XtensionsTASE:HUMX Stock Report

Last Price

₪4.49

Market Cap

₪120.1m

7D

-6.9%

1Y

-82.8%

Updated

20 Jan, 2022

Data

Company Financials
HUMX fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

HUMX Stock Overview

Human Xtensions Ltd. develops unmediated surgical systems.

Price History & Performance

Summary of all time highs, changes and price drops for Human Xtensions
Historical stock prices
Current Share Price₪4.49
52 Week High₪33.31
52 Week Low₪4.32
Beta0
1 Month Change-4.80%
3 Month Change-20.20%
1 Year Change-82.80%
3 Year Changen/a
5 Year Changen/a
Change since IPO-81.94%

Recent News & Updates

Oct 21
Here's Why We're Not Too Worried About Human Xtensions' (TLV:HUMX) Cash Burn Situation

Here's Why We're Not Too Worried About Human Xtensions' (TLV:HUMX) Cash Burn Situation

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

May 03
We Think Human Xtensions (TLV:HUMX) Can Afford To Drive Business Growth

We Think Human Xtensions (TLV:HUMX) Can Afford To Drive Business Growth

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Mar 03
What Type Of Shareholders Own The Most Number of Human Xtensions Ltd. (TLV:HUMX) Shares?

What Type Of Shareholders Own The Most Number of Human Xtensions Ltd. (TLV:HUMX) Shares?

Every investor in Human Xtensions Ltd. ( TLV:HUMX ) should be aware of the most powerful shareholder groups. Generally...

Shareholder Returns

HUMXIL Medical EquipmentIL Market
7D-6.9%-1.5%-1.2%
1Y-82.8%-2.6%37.7%

Return vs Industry: HUMX underperformed the IL Medical Equipment industry which returned -2.3% over the past year.

Return vs Market: HUMX underperformed the IL Market which returned 35.9% over the past year.

Price Volatility

Is HUMX's price volatile compared to industry and market?
HUMX volatility
HUMX Average Weekly Movement8.4%
Medical Equipment Industry Average Movement6.2%
Market Average Movement4.5%
10% most volatile stocks in IL Market8.6%
10% least volatile stocks in IL Market3.0%

Stable Share Price: HUMX is more volatile than 75% of IL stocks over the past 3 months, typically moving +/- 8% a week.

Volatility Over Time: HUMX's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of IL stocks.

About the Company

FoundedEmployeesCEOWebsite
201258Tami Frenkelhttps://human-x.com

Human Xtensions Ltd. develops unmediated surgical systems. It offers HandX, a handheld medical device for use in laparoscopic procedures. The company was founded in 2012 and is based in Netanya, Israel.

Human Xtensions Fundamentals Summary

How do Human Xtensions's earnings and revenue compare to its market cap?
HUMX fundamental statistics
Market Cap₪120.05m
Earnings (TTM)-₪52.98m
Revenue (TTM)₪2.79m

43.1x

P/S Ratio

-2.3x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
HUMX income statement (TTM)
Revenue₪2.79m
Cost of Revenue₪1.27m
Gross Profit₪1.52m
Expenses₪54.49m
Earnings-₪52.98m

Last Reported Earnings

Sep 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)-1.98
Gross Margin54.41%
Net Profit Margin-1,901.51%
Debt/Equity Ratio0%

How did HUMX perform over the long term?

See historical performance and comparison

Valuation

Is Human Xtensions undervalued compared to its fair value and its price relative to the market?

1.03x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate HUMX's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate HUMX's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: HUMX is unprofitable, so we can't compare its PE Ratio to the IL Medical Equipment industry average.

PE vs Market: HUMX is unprofitable, so we can't compare its PE Ratio to the IL market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate HUMX's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: HUMX is good value based on its PB Ratio (1x) compared to the IL Medical Equipment industry average (1.8x).


Future Growth

How is Human Xtensions forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

15.1%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Human Xtensions has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Human Xtensions performed over the past 5 years?

-72.0%

Last years earnings growth


Earnings and Revenue History

Quality Earnings: HUMX is currently unprofitable.

Growing Profit Margin: HUMX is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if HUMX's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Unable to compare HUMX's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: HUMX is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (8%).


Return on Equity

High ROE: HUMX has a negative Return on Equity (-45.54%), as it is currently unprofitable.


Financial Health

How is Human Xtensions's financial position?


Financial Position Analysis

Short Term Liabilities: HUMX's short term assets (₪123.8M) exceed its short term liabilities (₪9.1M).

Long Term Liabilities: HUMX's short term assets (₪123.8M) exceed its long term liabilities (₪6.8M).


Debt to Equity History and Analysis

Debt Level: HUMX is debt free.

Reducing Debt: HUMX has not had any debt for past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: HUMX has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: HUMX has sufficient cash runway for 2.2 years if free cash flow continues to reduce at historical rates of 16.3% each year.


Dividend

What is Human Xtensions's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate HUMX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate HUMX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if HUMX's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if HUMX's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of HUMX's dividend in 3 years as they are not forecast to pay a notable one for the IL market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

5.9yrs

Average board tenure


CEO

Tami Frenkel (59 yo)

no data

Tenure

₪1,354,000

Compensation

Dr. Tami Frenkel is Co-Founder and CEO at Human Xtensions Ltd. and has been its Director since January 01, 2012. She served as Vice President of Strategic Marketing of Visionsense Corp. Dr. Frenkel gained...


CEO Compensation Analysis

Compensation vs Market: Tami's total compensation ($USD433.03K) is about average for companies of similar size in the IL market ($USD403.40K).

Compensation vs Earnings: Insufficient data to compare Tami's compensation with company performance.


Board Members

Experienced Board: HUMX's board of directors are considered experienced (5.9 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Human Xtensions Ltd.'s employee growth, exchange listings and data sources


Key Information

  • Name: Human Xtensions Ltd.
  • Ticker: HUMX
  • Exchange: TASE
  • Founded: 2012
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Implied Market Cap: ₪120.054m
  • Shares outstanding: 26.76m
  • Website: https://human-x.com

Number of Employees


Location

  • Human Xtensions Ltd.
  • Grand Netter Building
  • 2nd floor
  • Netanya
  • 4250574
  • Israel

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/01/20 21:27
End of Day Share Price2022/01/20 00:00
Earnings2021/09/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.